Related Experiment Video
Updated: Jul 31, 2026
13:47
Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
Published on: June 23, 2011
Simplified catechin-gallate inhibitors of HIV-1 reverse transcriptase.
L M Tillekeratne1, A Sherette, P Grossman
1Department of Medicinal and Biological Chemistry, College of Pharmacy, University of Toledo, Toledo, OH 43606, USA.
Bioorganic & Medicinal Chemistry Letters
|October 10, 2001
Summary
Researchers simplified the molecular structures of epicatechin gallate and epigallocatechin gallate to find key features for inhibiting HIV-1 reverse transcriptase. These simplified compounds effectively blocked both normal and drug-resistant HIV-1 enzymes.
Area of Science:
- Medicinal Chemistry
- Virology
- Biochemistry
Background:
- HIV-1 reverse transcriptase is a key target for antiretroviral therapy.
- Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are crucial in HIV treatment.
- Drug resistance, particularly mutations like K103N and Y181C, poses a significant challenge.
Purpose of the Study:
- To identify the minimal structural requirements of epicatechin gallate and epigallocatechin gallate for HIV-1 reverse transcriptase inhibition.
- To develop novel compounds effective against drug-resistant HIV-1 strains.
Main Methods:
- Systematic structural simplification of epicatechin gallate and epigallocatechin gallate.
- In vitro enzymatic assays to assess inhibition of native and mutant HIV-1 reverse transcriptase.
- Characterization of structure-activity relationships.
Main Results:
- Several simplified compounds demonstrated potent inhibition of HIV-1 reverse transcriptase.
- These compounds were effective against both the wild-type enzyme and the double mutant (K103N Y181C).
- The A17 double mutant enzyme, typically resistant to NNRTIs, was significantly inhibited.
Conclusions:
- Minimal structural features of epicatechin gallate and epigallocatechin gallate are sufficient for potent HIV-1 reverse transcriptase inhibition.
- The identified compounds offer a promising starting point for developing new antiretrovirals against resistant HIV-1 strains.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...